HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N Okuno Selected Research

Therapeutics

4/2021Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N Okuno Research Topics

Disease

1Neoplasms (Cancer)
04/2021
1Prostatic Neoplasms (Prostate Cancer)
04/2021

Drug/Important Bio-Agent (IBA)

1Abiraterone AcetateIBA
04/2021
1AndrogensIBA
04/2021
1Prednisolone (Predate)FDA LinkGeneric
04/2021
1Prostate-Specific Antigen (Semenogelase)IBA
04/2021

Therapy/Procedure

1Castration
04/2021
1Drug Therapy (Chemotherapy)
04/2021
1Therapeutics
04/2021